ライフサイエンスコーパス: Pap smear

1 th high-grade SIL on colposcopy and referral Pap smear.

2 ening mammography, and 77% reported a recent Pap smear.

3 the impact of screening measures such as the Pap smear.

4 age of women with atypical squamous cells on Pap smear.

5 supplements the information provided by the Pap smear.

6 ol for the direct detection of TERC gains in Pap smears.

7 defined as at least three consecutive normal Pap smears.

8 g approximately 81,000 mammograms and 35,000 Pap smears.

9 igh-risk HPV cervical infection had abnormal Pap smears.

10 from screening mammography or Papanicolaou (Pap) smears.

11 001), and have undergone cancer screening by Pap smear (67.3% v 54.8%, P<.0001), mammogram (80.4% v 7

12 cificity (0.43 versus 0.93) for detection of Pap smear abnormalities, compared to Hybrid Capture.

13 3% [-8% to 45%]) among those who had >/= one Pap smear after enrollment.

14 se may decrease the number of false-negative Pap smears and are an option for laboratories.

15 eviously stained Pap smears for which repeat Pap smears and clinical follow-up were available.

16 Screening with Pap smears and mammography was assessed by questionnaire

17 screened for cervical and breast cancer with Pap smears and mammography, even after adjustment for ot

18 the new Bethesda System for the reporting of Pap smears and the new guidelines for the management of

19 participant received a vaginal examination, PAP smear, and completed a questionnaire.

20 Rates of recent screening mammography and Pap smears are high among older women in California.

21 uidelines for the management of the abnormal Pap smear by the American Society of Colposcopy and Cerv

22 Rescreening of Pap smears by PAPNET, followed by reevaluation of abnorm

23 amplification of TERC in routinely collected Pap smears can assist in identifying low-grade lesions w

24 ortion of these women who reported a current Pap smear did not change during the 10-year study period

25 s after the recommendation), 69.1% had had a Pap smear during the same period (P value for the compar

26 cal examination findings, anal Papanicolaou (Pap) smear findings.

27 obe set to a series of 59 previously stained Pap smears for which repeat Pap smears and clinical foll

28 essed spontaneously (regressors), and normal Pap smears from women who subsequently developed CIN3 or

29 ain was found in 33% of cytologically normal Pap smears from women who were diagnosed with CIN3 or in

30 reening for cervical abnormalities using the Pap smear has achieved a substantial reduction in morbid

31 ferred for colposcopy because of an abnormal Pap smear in cervical-cancer screening can be treated by

32 undergone hysterectomy reported having had a Pap smear in the past 3 years; in 2002 (6 years after th

33 (78%) than normal-weight women (84%) had had Pap smears in the previous 3 years (P < 0.001).

34 The risk of an abnormal Pap smear increased with persistent HPV infection, parti

35 The introduction of liquid Pap smear methods using exfoliated cervical cells presen

36 h men >/= 5 years older, history of abnormal PAP smear, older age, and living separately from parents

37 ram/X-ray (OR = 1.27, 95% CI = 1.16-1.39) or pap smear (OR = 1.16, 95% CI = 1.06-1.28), and males wer

38 ispanic females less likely to have a recent Pap smear (OR, 0.7; 95% CI, 0.5 to 1.0); black and Hispa

39 plasma levels were associated with abnormal Pap smears (P=.01; relative risk, 2.11).

40 The repeat Pap smear result was abnormal in 76.2% (95% CI, 63.5%-85

41 At screening visits only HPV test and Pap smear samples were collected, and at biopsy visits c

42 Ninety-four Pap smear samples with a cytological diagnosis of ASCUS

43 patients tested by clinical human biopsy or pap smear samples.

44 DNA from cervical cells, collected with the Pap smear sampling method, was spiked with HPV-16 DNA an

45 Many US women are undergoing Pap smear screening even though they are not at risk of

46 research has focused on new technologies for Pap smear screening such as thin layer technology, the a

47 Force recommended that routine Papanicolaou (Pap) smear screening is unnecessary for these women.

48 V) DNA testing of women having Papanicolaou (Pap) smears showing atypical squamous cells of undetermi

49 ver, results to date suggest that thin layer Pap smear technology may improve sensitivity in the dete

50 n reduce the high false-negative rate of the Pap smear test and may facilitate mass automated screeni

51 patients with positive result from standard Pap smear test, indicating that an electrochemical immun

52 Papanicolaou (Pap) smear tests have reduced mortality by up to 70%.

53 After accounting for Pap smears that may have preceded a recent hysterectomy

54 zed image analysis to rescreen Papanicolaou (Pap) smears that have already been examined by cytotechn

55 Pap smears were obtained annually.

56 Cervical lavage samples and Pap smears were obtained from 284 women in Malawi to eva

57 ecialty, rate differences for screening with Pap smears were still seen among overweight (-3.5% [95%

58 within the previous 2 years and a screening Pap smear within 3 years.

59 story of hysterectomy who reported a current Pap smear (within 3 years).